The Neutrophil-to-Monocyte Ratio and Platelet-to-White Blood Cell Ratio Represent Novel Prognostic Markers in Patients with Pancreatic Cancer

Table 2

Comparison of different blood cell count and inflammatory markers in patients with different survival time groups.

Variables					AUC
CA199 (U/mL)	203.4 (30.70-400.00)	400.0 (48.2-400.0)	3.059	0.002	0.606
WBC (×10^9/L)	6.4 (5.10-8.70)	7.5 (5.3-10.3)	2.089	0.037	0.574
NEU (×10^9/L)	4.6 (3.50-6.50)	5.7 (3.8-8.0)	2.558	0.011	0.590
Mono (×10^9/L)	0.43 (0.33-0.62)	0.48 (0.33-0.66)	1.398	0.162	0.594
LYM (×10^9/L)	1.1 (0.8-1.4)	0.9 (0.7-1.3)	2.361	0.018	0.583
PLT (×10^9/L)	191.5 (137.0-242.0)	202.0 (147.5-246.5)	1.125	0.260	0.540
BASO (×10^9/L)	0.03 (0.01-0.06)	0.02 (0.01-0.06)	0.314	0.753	0.511
EOS (×10^9/L)	0.08 (0.01-0.23)	0.05 (0.01-0.12)	2.645	0.008	0.593
ALB (g/L)	40.4 (37.4-43.2)	37.3 (34.1-42.1)	3.527	<0.001	0.625
LMR	2.6 (1.7-3.6)	2.1 (1.3-3.1)	2.981	0.003	0.605
PLR	169.3 (125.8-233.3)	204.3 (129.1-307.3)	2.860	0.004	0.601
NLR	4.4 (2.8-7.3)	6.0 (3.5-10.0)	3.248	0.001	0.615
dNLR	2.8 (1.8-3.9)	3.2 (2.4-4.9)	2.602	0.009	0.592
NMR	10.9 (7.9-13.2)	115.0 (96.5-130.0)	13.916	<0.001	0.992
PWR	27.8 (20.5-38.3)	4.1 (3.5-4.5)	13.926	<0.001	0.992
PNR	40.9 (25.6-57.4)	36.1 (25.7-50.1)	1.467	0.142	0.552
PMR	403.1 (321.4-595.1)	432.7 (309.4-632.2)	0.018	0.986	0.501
PAR	4.8 (3.5-6.1)	5.2 (3.8-6.8)	2.118	0.034	0.575

WBC: white blood cell; NEU: neutrophil; mono: monocyte; LYM: lymphocyte; PLT: platelet; BASO: basophil; EOS: eosinophil; ALB: albumin; LMR: lymphocyte-to-monocyte ratio; PLR: platelet-to-lymphocyte ratio; NLR: neutrophil-to-lymphocyte ratio; dNLR: absolute count of neutrophils divided by the absolute white cell count minus the absolute count of neutrophils; NMR: neutrophil-to-monocyte ratio; PWR: platelet-to-white blood cell ratio; PNR: platelet-to-neutrophil ratio; PMR: platelet-to-monocyte ratio; PAR: platelet-to-albumin ratio.